SCHEMBL6316992

SCHEMBL6316992

C[C@H](N)C(=O)Oc1ccc(O)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 3/20 0.39
PRMT6 Q96LA8 3/20 0.39
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
ALOX15 P16050 1/20 0.36
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA7 P43166 2/20 0.35
CA9 Q16790 2/20 0.35
CA14 Q9ULX7 2/20 0.35
MIF P14174 1/20 0.35
PRSS1 P07477 4/20 0.34
TMPRSS15 P98073 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28063973 0.85 L3MBTL1 (0.46) CARM1PRMT6PDE4APDE4BPDE4C
SCHEMBL5878457 0.80 CARM1 (0.35) CARM1PRMT6PDE4APDE4BPDE4C
SCHEMBL27999254 0.80 CARM1 (0.36) CARM1PRMT6PDE4APDE4BPDE4C
SCHEMBL15670768 0.78 ALDH1A1 (0.51) CARM1PRMT6LMNA
SCHEMBL2014680 0.78 ALDH1A1 (0.51) CARM1PRMT6LMNA
SCHEMBL4318565 0.78 MIF (0.40) LMNAMAPK1HTTRAB9AMIF
SCHEMBL12987528 0.78 CYP4F2 (0.49) LMNAMAPK1HTTRAB9AMIF
SCHEMBL23215816 0.77 ALOX15 (0.47) LMNAMAPK1HTTALOX15
SCHEMBL1527382 0.77 PDE4A (0.38) CARM1PRMT6PDE4APDE4BPDE4C
SCHEMBL27945186 0.75 CYP4F2 (0.41) CARM1PRMT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143581-A1 Process for preparation of alkoxybenzamides and thiazolyl isocyanates MITSUI CHEMICALS, INC. (JP) 2005-06-30 US disclosed
EP-1489073-A1 PROCESS FORPREPARATION OF ALKOXYBENZAMIDES AND THIAZOLYL ISOCYANATES MITSUI CHEMICALS, INC. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143581-A1 Process for preparation of alkoxybenzamides and thiazolyl isocyanates CBR3, CBR1, IDH1 CARM1 1007/4885PRMT6 112/4885PDE4A 4687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.